It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1981.
1981 | Mumbai, Maharashtra, India | ActiveTridoss Laboratories Private Limited, a active private limited company, was established on 05 October 1981 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH1981PTC025373. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.15 Cr.
Formerly known as Tridoss Laboratories Limited, Wockhardt Laboratories Pvt Ltd. It upholds a compliant status. Its leadership includes Nargis Akhtar Shamsi (Director), Akhtar Fakhruddin Shamsi (Director). Past directors included Nargis Akhtar Shamsi, Akhtar Fakhruddin Shamsi, Ridhi Uttam Mehta. It holds ₹17.05 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2Nd Floor Room No 8167 Readymaoey Terrace Drannie Besant Rd Worli, Mumbai, Maharashtra, 400018.
U24230MH1981PTC025373
025373
05 October 1981
₹10.00 Cr
₹9.15 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Tridoss Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nargis Akhtar Shamsi | Director | 02 Sep 2002 | Current |
| Akhtar Fakhruddin Shamsi | Director | 02 Sep 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jan 2019 | Past |
| Pramod Abcsdd | Director | 31 Jan 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tridoss Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.43% decrease. The company also saw a substantial improvement in profitability, with a 756.08% increase in profit. The company's net worth moved up by a moderate rise of 5.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Tridoss Laboratories had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹170,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 1997 | Standard Chartered Bank | ₹9.50 Cr | Open |
| 22 Mar 1996 | Banque Nationale De Paris | ₹6.00 Cr | Open |
| 21 Jun 1993 | The British Bank Of The Middle Eat | ₹1.25 Cr | Open |
| 19 Nov 1982 | Dena Bank | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Tridoss Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tridoss Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tridoss Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Tridoss Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Tridoss Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Nargis Akhtar Shamsi was appointed as a Director was appointed as a Director on 02 Sep 2002 & has been associated with this company since 23 years 3 months . was completed.
The activity Akhtar Fakhruddin Shamsi was appointed as a Director was appointed as a Director on 02 Sep 2002 & has been associated with this company since 23 years 3 months . was completed.
A charge with Standard Chartered Bank amounted to Rs. 9.50 Cr with Charge ID 90188685 was registered on 19 Jun 1997. was recorded as a recent event.
A charge with Banque Nationale De Paris amounted to Rs. 6.00 Cr with Charge ID 90188642 was registered on 22 Mar 1996. was recorded as a recent event.
The CIN of Tridoss Laboratories Private Limited is U24230MH1981PTC025373.
Tridoss Laboratories Private Limited is headquartered at 2Nd Floor Room No 8167 Readymaoey Terrace Drannie Besant Rd Worli, Mumbai, Maharashtra, 400018.
Tridoss Laboratories Private Limited was incorporated on 05 October 1981.
The current directors of Tridoss Laboratories Private Limited are
The primary industry of Tridoss Laboratories Private Limited is Trade.
Tridoss Laboratories Private Limited is unlisted.
The authorized capital of Tridoss Laboratories Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.15 Cr.
The compliance status of Tridoss Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX